The Centers for Medicare and Medicaid Services (CMS) announced on February 5, 2015, that CT lung cancer screening will be a covered service. This long awaited decision followed the preliminary announcement in November 2014. After a period of comment, the coverage ages were expanded to include patients 55-77 years old. The process mandates maintena
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung - Cancer
February 3, 2015
This consensus statement from the European Neuroendocrine Society is based on extensive bibliographic searches and systematic review. Surgery is the mainstay of therapy for most tumors, and includes resection of metastases when this can be accomplished in a curative manner. Somatostatin analogues are considered first line therapy for unresectable c
February 2, 2015
The authors queried the National Cancer Data Base to assess outcomes of patients with R1 resection margins related to the presence and type of postoperative adjuvant therapy. 3.1% of over 54,000 resections had R1 margins, which negatively affected long-term survival. Combined chemotherapy and radiation therapy improved outcomes; administration of c
February 2, 2015
This study propensity-score matched patients from a cohort who underwent resection for stage I or II lung cancer and compared 175 pairs who underwent VATS or open lobectomy. The VATS group experienced shorter hospital length of stay, fewer complications, and more frequent discharge to home. Survival was similar.
January 29, 2015
This meta-analysis of 6 prior publications analyzed factors associated with outcomes after resection of synchronous lung cancers. Favorable predictors of survival were exclusive adenocarcinoma, small T size, bilateral disease, no nodal involvement, young age, and female sex.
January 29, 2015
There is growing recognition of the utility of EBUS in staging NSCLC. In this study EBUS and mediastinoscopy were performed in 127 patients requiring mediastinal staging for clinical N1-3 NSCLC. The authors found that EBUS had superior accuracy (93% vs 89%) and negative predictive value (85% vs 79%).
January 29, 2015
This analysis of nearly 40,000 patients with inoperable early stage lung cancer explored factors associated with delivery of potentially curative conventional radiotherapy (ConvRT) or SBRT. Treatment was less likely in blacks and hispanics. SBRT was more likely than ConvRT in high volume and academic centers. Overall use of SBRT, ConvRT, and no tr
January 20, 2015
This video depicts a minimal invasive approach for the surgical resection of a large superior sulcus tumor that involves the secend rib and T1 nerve root.
January 15, 2015
Filmed at the 2014 STS Annual Meeting in Orlando, Florida, this roundtable discussion focuses on mediastinal staging for non-small cell lung cancer. Frank Detterbeck moderates this discussion with Moishe Liberman and Luis Herrera.
December 10, 2014
This interesting article summarizes the evidence from clinical, radiologic and pathologic investigations that lung cancer, specifically adenocarcinoma, may metastasize through the airways, defined as discontinuous spread of cancer cells from the primary tumor through the airways to adjacent or distant lung parenchyma.